Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Depression Treatment: A Lifelong Commitment?
1
x
$
30.00
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
1
x
$
30.00
Divalproex in the Treatment of Migraine
1
x
$
30.00
The Use of Divalproex in the Treatment of Addictive Disorders
1
x
$
30.00
Generalized Anxiety Disorder: Raising the Expectations of Treatment
1
x
$
30.00
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
1
x
$
30.00
The Efficacy of Divalproex for Partial Epilepsies
1
x
$
30.00
View Cart
Checkout
Home
psychiatric-status-rating-scales
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 3, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Page load link
Go to Top
